Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)

Thumbnail
Date
2020
Author
Ugurel, O.M.
Mutlu, O.
Sariyer, E.
Kocer, S.
Ugurel, E.
Inci, T.G.
Ata, O.
Turgut-Balik, D.
Metadata
Show full item record
Abstract
SARS-CoV-2 has caused COVID-19 outbreak with nearly 2 M infected people and over 100K death worldwide, until middle of April 2020. There is no confirmed drug for the treatment of COVID-19 yet. As the disease spread fast and threaten human life, reposition
URI
https://doi.org/10.1016/j.ijbiomac.2020.09.138
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1140
Collections